ストックスクリーナーアプリを入手
5.67
1.25%
0.07
前日終値:
$5.60
開ける：
$5.6
24時間の取引高:
2.27M
Relative Volume:
0.28
時価総額：
$442.58M
収益：
-
当期純損益:
$-209.96M
株価収益率:
-1.7943
EPS:
-3.16
ネットキャッシュフロー:
$-176.27M
1週間 パフォーマンス:
+1.98%
1か月 パフォーマンス:
+102.14%
6か月 パフォーマンス:
-59.44%
1年 パフォーマンス:
-44.08%
1日の値動き範囲:
$5.53
$5.818
1週間の範囲:
$5.08
$5.818
52週間の値動き範囲:
$2.68
$17.00
Replimune Group Inc Stock (REPL) Company Profile
REPL を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
REPL
Replimune Group Inc
|
5.67 | 416.04M | 0 | -209.96M | -176.27M | -3.16 |
|
VRTX
Vertex Pharmaceuticals Inc
|
395.12 | 99.96B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
589.48 | 60.83B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
454.38 | 59.89B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
660.00 | 40.47B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
313.67 | 37.96B | 3.81B | -644.79M | -669.77M | -6.24 |
Replimune Group Inc Stock (REPL) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-07-30 | アップグレード | Cantor Fitzgerald | Neutral → Overweight |
| 2025-07-23 | ダウングレード | BMO Capital Markets | Outperform → Underperform |
| 2025-07-23 | ダウングレード | Barclays | Overweight → Equal Weight |
| 2025-07-23 | ダウングレード | H.C. Wainwright | Buy → Neutral |
| 2025-07-22 | ダウングレード | JP Morgan | Overweight → Neutral |
| 2025-07-22 | ダウングレード | Leerink Partners | Outperform → Market Perform |
| 2025-07-22 | ダウングレード | Piper Sandler | Overweight → Neutral |
| 2025-07-22 | ダウングレード | Wedbush | Outperform → Neutral |
| 2025-06-20 | 開始されました | Cantor Fitzgerald | Overweight |
| 2024-08-28 | 開始されました | ROTH MKM | Buy |
| 2023-04-17 | 再開されました | Piper Sandler | Overweight |
| 2021-11-19 | 開始されました | Piper Sandler | Overweight |
| 2021-10-15 | 再開されました | BTIG Research | Buy |
| 2020-11-17 | 開始されました | BTIG Research | Buy |
| 2020-11-02 | 開始されました | Jefferies | Buy |
| 2020-10-15 | アップグレード | H.C. Wainwright | Neutral → Buy |
| 2020-07-01 | ダウングレード | H.C. Wainwright | Buy → Neutral |
| 2020-05-05 | 開始されました | Barclays | Overweight |
| 2019-09-04 | 開始されました | ROTH Capital | Buy |
| 2019-07-23 | 開始されました | Chardan Capital Markets | Buy |
| 2019-07-12 | アップグレード | JP Morgan | Neutral → Overweight |
| 2019-07-08 | 開始されました | H.C. Wainwright | Buy |
| 2019-04-25 | 開始されました | Wedbush | Outperform |
| 2019-01-23 | ダウングレード | JP Morgan | Overweight → Neutral |
| 2018-08-14 | 開始されました | JP Morgan | Overweight |
| 2018-08-14 | 開始されました | Leerink Partners | Outperform |
すべてを表示
Replimune Group Inc (REPL) 最新ニュース
REPL Investors Have the Opportunity to Lead the Replimune Securities Fraud Lawsuit with Faruqi & Faruqi, LLP - GlobeNewswire
Biotech Replimune Faces Derivative Suit Over Trial Claims - Law360
Replimune (REPL) Faces Securities Class Action Following - GlobeNewswire
Did You Lose Money on Replimune Group, Inc. (REPL)? Levi & Korsinsky Urges Investors to Act Before September 22, 2025 - ACCESS Newswire
Will Replimune Group Inc. see short term momentum2025 Buyback Activity & Stepwise Entry and Exit Trade Signals - Newser
US Bancorp DE Buys 3,921 Shares of Replimune Group, Inc. $REPL - Defense World
Using R and stats models for Replimune Group Inc. forecasting2025 Market Overview & Risk Managed Investment Entry Signals - Newser
What technical models suggest about Replimune Group Inc.’s comebackEarnings Overview Report & AI Forecasted Entry and Exit Points - Newser
Is Replimune Group Inc. stock reversal real or fakePortfolio Profit Report & Verified Momentum Stock Alerts - Newser
Applying big data sentiment scoring on Replimune Group Inc.July 2025 Spike Watch & Weekly Setup with High ROI Potential - Newser
Published on: 2025-08-19 23:50:57 - Newser
Replimune (REPL) Faces Securities Class Action Following Stock’s Collapse Amid FDA’s Rejection of Melanoma DrugHagens Berman - ACCESS Newswire
What moving averages say about Replimune Group Inc.Market Volume Report & Expert Curated Trade Setup Alerts - Newser
Investor Alert: Deadline Approaching to Join Replimune Group, Inc. (REPL) Class ActionContact Levi & Korsinsky - Newsfile
Shareholders of Replimune Group, Inc. Should Contact Levi & - GlobeNewswire
What earnings revisions data tells us about Replimune Group Inc.Weekly Profit Report & Community Trade Idea Sharing - Newser
How institutional ownership impacts Replimune Group Inc. stockQuarterly Growth Report & Weekly Top Performers Watchlists - Newser
Replimune Group, Inc. (REPL) Investors: September 22, 2025 Filing Deadline in Securities Class ActionContact Kessler Topaz Meltzer & Check, LLP - FinancialContent
Replimune Group Inc.’s volatility index tracking explainedMarket Volume Report & High Win Rate Trade Tips - Newser
Class Action Filed Against Replimune Group, Inc. (REPL)September 22, 2025 Deadline to JoinContact Levi & Korsinsky - MarketScreener
Lost Money on Replimune Group, Inc. (REPL)? Contact Levi & Korsinsky to Join Class Action Before September 22, 2025 - ACCESS Newswire
Is Replimune Group Inc. a candidate for recovery playMarket Activity Summary & Expert Verified Stock Movement Alerts - Newser
How to interpret RSI for Replimune Group Inc. stockEarnings Miss & Breakout Confirmation Alerts - Newser
Replimune Group, Inc. Class Action: The Gross Law Firm - GlobeNewswire
Time to SueWallSt? Levi & Korsinsky Files Lawsuit Over Replimune Group, Inc. Stock Losses - Stockhouse
Class Action Alert: Levi & Korsinsky Reminds Replimune Group, Inc. (REPL) Investors of September 22, 2025 Deadline - ACCESS Newswire
Class Action Lawsuit Filed Against Replimune Group, Inc. (REPL)Recover LossesContact Levi & Korsinsky Before September 22, 2025 - ACCESS Newswire
Contact The Gross Law Firm by September 22, 2025 Deadline to Join Class Action Against Replimune Group, Inc.(REPL) - PR Newswire
SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A - GlobeNewswire
How to recover losses in Replimune Group Inc. stockPortfolio Risk Report & Free Long-Term Investment Growth Plans - Newser
REPL Investors Have Opportunity to Lead Replimune Group, Inc. Securities Fraud Lawsuit with the Schall Law Firm - MarketScreener
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Replimune Group, Inc. of Class Action Lawsuit and Upcoming Deadlines – REPL - FinancialContent
Replimune Group, Inc. (REPL) Class Action Lawsuit: Levi & Korsinsky Reminds Investors of September 22, 2025 Deadline - ACCESS Newswire
2025-08-17 | REPL SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Replimune Group, Inc. Shareholders Have Opportunity to Lead Class Action Lawsuit! | NDAQ:REPL | Press Release - Stockhouse
Is Replimune Group Inc. trending in predictive chart models2025 AllTime Highs & Verified Chart Pattern Trade Signals - Newser
REPL Investor Alert: A Securities Fraud Class Action Lawsuit Has Been Filed Against Replimune Group, Inc. (REPL)Contact Kessler Topaz Meltzer & Check, LLP - FinancialContent
ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Replimune - GlobeNewswire
ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Replimune Group, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm – REPL - GlobeNewswire Inc.
Bragar Eagel & Squire, P.C. Reminds Investors of Class - GlobeNewswire
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Replimune Group, Inc. of Class Action Lawsuit and Upcoming DeadlinesREPL - PR Newswire
ROSEN, THE FIRST FILING FIRM, Encourages Replimune Group, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by The FirmREPL - ACCESS Newswire
Lawsuit filed for Investors who lost money with shares of Replimune Group, Inc. (NASDAQ: REPL) - openPR.com
Shareholders of Replimune Group, Inc. (REPL): Protect Your Rights Before September 22, 2025Contact Levi & Korsinsky - ACCESS Newswire
Faruqi & Faruqi Reminds Replimune Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of September 22, 2025REPL - MarketScreener
Class Action Announcement for Replimune Group, Inc. (REPL): Kessler Topaz Meltzer & Check, LLP Announces that a Securities Class Action Lawsuit Has Been Filed Against Replimune Group, Inc. - MarketScreener
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of September 22, 2025 in Replimune Group, Inc. LawsuitREPL - PR Newswire
Replimune Group Stock Soars 17.76% Amid FDA Rejection Lawsuit - AInvest
Momentum divergence signals in Replimune Group Inc. chart2025 Biggest Moves & Safe Swing Trade Setups - Newser
Replimune Group’s SWOT analysis: oncology biotech stock faces FDA hurdles - Investing.com
Replimune Group, Inc. shares rise 11.59% after-hours following securities class action lawsuits. - AInvest
REPL LAWSUIT ALERT: Levi & Korsinsky Notifies Replimune Group, Inc. Investors of a Class - Bluefield Daily Telegraph
Replimune Group Inc (REPL) 財務データ
収益
当期純利益
現金流量
EPS
Replimune Group Inc (REPL) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Astley-Sparke Philip | Director |
May 20 '25 |
Sale |
8.06 |
32,279 |
260,169 |
1,405,071 |
| Xynos Konstantinos | Chief Medical Officer |
May 20 '25 |
Sale |
8.06 |
7,952 |
64,093 |
146,933 |
| Schwendenman Andrew | Chief Accounting Officer |
May 20 '25 |
Sale |
8.05 |
3,287 |
26,460 |
68,284 |
| Patel Sushil | Chief Executive Officer |
May 20 '25 |
Sale |
8.06 |
25,105 |
202,346 |
343,576 |
| Hill Emily Luisa | Chief Financial Officer |
May 20 '25 |
Sale |
8.05 |
2,535 |
20,407 |
143,522 |
| Sarchi Christopher | Chief Commercial Officer |
May 20 '25 |
Sale |
8.05 |
3,749 |
30,179 |
128,296 |
| Patel Sushil | Chief Executive Officer |
Dec 16 '24 |
Sale |
12.42 |
10,000 |
124,200 |
202,014 |
0.94%
1.72%
大文字化:
|
ボリューム (24 時間):